Search for European Projects

10 European Projects Found

Searched on 125080 European Projects

 FINISHED 

Mutanome Engineered RNA Immuno-Therapy (MERIT)

Start date: Jun 1, 2013, End date: Nov 30, 2017,

The Mutanome Engineered RNA Immuno-Therapy (MERIT) project aims to clinically translate and industrially validate a pioneering RNA-based immunotherapy approach to target the individual tumour antigen signature. MERIT focuses on previous inventions, fits into the overall business and innovation needs of the partners, and addresses triple-negative breast cancer patients with high medical need. The M ...
Read Project

 5

 FINISHED 

Novel drug delivery system produced by centrifugal technologies – composed to minimize adverse immune reactions and designed for optimised therapeutic effects (decent AID)

Start date: Apr 1, 2013, End date: Mar 31, 2017,

Drug delivery systems are a matter of intensive scientific investigation and technological developments. They are necessary since many active pharmaceutical ingredients to be employed in therapy, diagnostics or vaccination cause serious side effects when distributed non-specifically. Without a drug delivery system, the active pharmaceutical ingredients may accumulate in healthy and sensitive tissu ...
Read Project

 4

 FINISHED 

Tumor Infiltrating Myeloid Cell Compartment (TIMCC)

Start date: Nov 1, 2012, End date: Oct 31, 2016,

"The ITN TIMCC brings together eight expert teams from different disciplines within Immunology, Genetics and Oncology, to provide substantive and methodological training in the analysis of the role of the Tumor Infiltrating Myeloid Cell Compartment (TIMCC) of the innate immune system. Leukocytes recruited to (pre)malignant tissues are mainly myeloid cells. They can either prevent or functionally c ...
Read Project

 8

 FINISHED 

Development of RApid Point-of-Care test Platforms for Infectious Diseases (RAPP-ID)

Start date: Apr 1, 2011, End date: Sep 30, 2016,

RAPP-ID (“Development of RApid Point-of-Care test Platforms for Infectious Diseases”) will develop a Point-of-Care Test (POCT) for rapid (hospital
Read Project

 20

 FINISHED 

Novel diagnostic bio-assays based on magnetic particles (BIOMAX)

Start date: Feb 1, 2011, End date: Jan 31, 2015,

Nanotechnology-based in-vitro diagnostics is set to solve several important problems in global healthcare. R&D in this field requires collaborations between experts from different scientific disciplines with a strong focus on the integration of bio-, nano- and microtechnologies. However, such personnel is still scarce. This BioMaX training-through-research network responds to the need for skilled ...
Read Project

 7

 FINISHED 

Two Stage Rapid Biological Surveillance and Alarm System for Airborne Pathogenic Threats (TWOBIAS)

Start date: Jul 1, 2010, End date: Dec 31, 2013,

"The aim of this project is to develop a demonstrable, modular and “close-to-market” demonstrator of a stationary rapid reliable vehicle-portable Two Stage Rapid Biological Surveillance and Alarm System for Airborne Threats (TWOBIAS) with extremely low false alarm rates. TWOBIAS will provide reliable information to command control systems (CCS) and first responders within seconds, enhancing securi ...
Read Project

 11

 FINISHED 

"Early diagnosis, treatment and prevention of mood disorders targetting the activated inflammatory response system" (MOODINFLAME)

Start date: Nov 1, 2008, End date: Apr 30, 2013,

"Partners come from 10 European countries to achieve two main objectives: A) The further exploration of 3 animal models (the OBX rat, GS rat and NOD mouse) characterized by an activated immune response system (IRS), an abnormal tryptophan catabolism and a depressive-like behaviour to study the pathogenesis of inflammation-related mood disorders and the efficacy/working mechanism of anti-inflammat ...
Read Project

 21

 FINISHED 

REvolutionary Approaches and Devices for Nucleic Acid Analysis (READNA)

Start date: Jun 1, 2008, End date: Nov 30, 2012,

"The REvolutionary Approaches and Devices for Nucleic Acid analysis – READNA – consortium is composed of researchers from 10 academic institutions, 5 SMEs and 3 large companies. The goals of the READNA consortium are to revolutionize nucleic acid analysis methods, by 1) improving elements necessary to use the currently emerging generation of nucleic acid sequencers in a meaningful and accessible w ...
Read Project

 20

 FINISHED 

Advanced affinity tools and technologies for high throughput studies of the human proteome (AffinityProteome)

Start date: Mar 1, 2009, End date: Feb 29, 2012,

High specificity affinity reagents (‘binders’) are essential probes for proteome research, enabling the detection and localisation of multiple proteins in tissues and fluids in health and disease, through the application of binder-based technologies (affinity proteomics). This proposal links the high throughput production of quality-controlled, recombinant binding molecules of different types (ant ...
Read Project

 10

 FINISHED 

European Genetic Disease Diagnostics (EURO-GENE-SCAN)

Start date: Jan 1, 2009, End date: Dec 31, 2011,

"Molecular techniques have become more efficient, increasingly precise and much cheaper, resulting in an unprecedented discovery rate of inherited disease genes. In areas such as primary immunodeficiencies (PID), muscle disorders, growth deficiencies, hearing/vision impairments and metabolic diseases, very large numbers of different genes have been found to carry mutations in diseases with heterog ...
Read Project

 5